Compliance with Group B Streptococcus Testing Prior to Labor and Delivery

ABSTRACT

We tested whether group B streptococcus (GBS) screening is performed as recommended by the Centers for Disease Control and Prevention (CDC) and evaluated the need for a rapid GBS test for women with full-term pregnancies. A retrospective cohort analysis at a single, large academic institution was performed. Women who delivered full-term (>37 weeks) infants and had documented prenatal care were included. The primary outcome was documented screening. One hundred sixty-five full-term pregnancies were included; 158 women [95.76%; 95% confidence interval (CI), 92.68 to 98.83%] were screened prior to presentation at labor and delivery. This frequency was significantly greater than the a priori hypothesis of 90% (p = 0.01). Of the 158 women ever screened, 15 had GBS bacteriuria and 143 had genital culture performed. However, only 118 of the 143 (80.61%; 95% CI, 74.57 to 86.64%) were cultured at the appropriate time as recommended by the CDC (between 35 and 37 weeks). This screening frequency was significantly lower than the a priori hypothesis of 90% (p < 0.001). Most full-term women presenting to labor and delivery have been screened for GBS. However, screening performed at the appropriate gestational age per CDC recommendations was lower than expected. Rapid GBS testing does not appear to be necessary for this population.

Group B streptococcus - prenatal screening - rapid GBS testing - full-term women

REFERENCES

• 1 Bergeron M G, Ke D, Ménard C et al.. Rapid detection of group B streptococci in pregnant women at delivery.  N Engl J Med. 2000;  343 175-179
• 2 Gibbs R S, Schrag S, Schuchat A. Perinatal infections due to group B streptococci.  Obstet Gynecol. 2004;  104(5 Pt 1) 1062-1076
• 3 Pettersson K. Perinatal infection with group B streptococci.  Semin Fetal Neonatal Med. 2007;  12 193-197
• 4 Law M R, Palomaki G, Alfirevic Z et al.. The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Society.  J Med Screen. 2005;  12 60-68
• 5 Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.  MMWR Recomm Rep. 2002;  51(RR-11) 1-22
• 6 Benitz W E, Gould J B, Druzin M L. Preventing early-onset group B streptococcal sepsis: strategy development using decision analysis.  Pediatrics. 1999;  103 e76
• 7 Centers for Disease Control and Prevention (CDC) . Perinatal group B streptococcal disease after universal screening recommendations—United States, 2003-2005.  MMWR Morb Mortal Wkly Rep. 2007;  56 701-705
• 8 Matteson K A, Lievense S P, Catanzaro B, Phipps M G. Intrapartum group B streptococci prophylaxis in patients reporting a penicillin allergy.  Obstet Gynecol. 2008;  111(2 Pt 1) 356-364
• 9 Centers for Disease Control and Prevention . Prevention of perinatal group B streptococcal disease: A public health perspective.  MMWR Recomm Rep. 1996;  45(RR-7) 1-24
• 10 Yancey M K, Schuchat A, Brown L K, Ventura V L, Markenson G R. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery.  Obstet Gynecol. 1996;  88 811-815
• 11 Davies H D, Miller M A, Faro S, Gregson D, Kehl S C, Jordan J A. Multicenter study of a rapid molecular-based assay for the diagnosis of group B Streptococcus colonization in pregnant women.  Clin Infect Dis. 2004;  39 1129-1135
• 12 Rallu F, Barriga P, Scrivo C, Martel-Laferrière V, Laferrière C. Sensitivities of antigen detection and PCR assays greatly increased compared to that of the standard culture method for screening for group B streptococcus carriage in pregnant women.  J Clin Microbiol. 2006;  44 725-728
• 13 Convert M, Martinetti Lucchini G, Dolina M, Piffaretti J C. Comparison of LightCycler PCR and culture for detection of group B streptococci from vaginal swabs.  Clin Microbiol Infect. 2005;  11 1022-1026